JPET Celsis microsomes equal better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by BLISS, E. L.
Right arrow Articles by AILION, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by BLISS, E. L.
Right arrow Articles by AILION, J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 168, Issue 2, 258-263, 1969
Copyright © 1969 by American Society for Pharmacology and Experimental Therapeutics


RESPONSE OF NEUROGENIC AMINES TO AGGREGATION AND STRANGERS

EUGENE L. BLISS 1 and JANIE AILION 1

1 Department of Psychiatry, University of Utah College of Medicine, Salt Lake City, Utah

Aggregation of mice who were strangers to one another resulted in a decrease in brain norepinephrine and an increase in its rate of catabolism. Serotonin levels remain unchanged, although concentration of 5-hydroxyindoleacetic acid in brain increased, indicating an increased catabolism of serotonin as well. Dopamine levels in brain and its catabolism were unaffected. At the same time no changes in norepinephrine metabolism could be detected in the adrenal, heart or spleen. The intermingling of strangers without aggregation also decreased brain norepinephrine. A more severe stress of footahock to rats not only diminished brain norepinephrine but also radically reduced catecholamine levels in the adrenal and spleen. These observations suggest that emotional disturbances activate the norepinephrine and serotonin systems in brain. In the case of norepinephrine these changes are first detectable in brain, but a more intense activation produces a further reduction of brain norepinephrine, now associated with decreases in norepinephrine in the peripheral organs.

Submitted on December 2, 1968
Accepted on April 21, 1969







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1969 by the American Society for Pharmacology and Experimental Therapeutics.